A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis

Neurology

Volumn 58, Issue 11, 2002, Pages 1652-1659

  Freitag, F G ^a   Collins, S D ^b,c   Carlson, H A ^b   Goldstein, J ^d   Saper, J ^e   Silberstein, S ^f   Mathew, N ^g   Winner, P K ^h   Deaton, R ^b   Sommerville, K ^b  

^a DIAMOND HEADACHE CLINIC   (United States)

^b ABBOTT LABORATORIES   (United States)

^c RW Johnson PRD   (United States)

^d San Francisco Headache Clinic   (United States)

^e Michigan Head Pain and Neurological Institute   (United States)

^f JEFFERSON HEADACHE CENTER   (United States)

^g Houston Headache Clinic   (United States)

^h Palm Beach Headache Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEPAKOTE ER; VALPROATE SEMISODIUM;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIARRHEA; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; DYSPEPSIA; FEMALE; FLU LIKE SYNDROME; HUMAN; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; SOMNOLENCE; UNITED STATES; VOMITING; WEIGHT GAIN;

EID: 0037062572     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.11.1652     Document Type: Article

References (18)

1. Possible mechanisms of valproate in migraine prophylaxis
2. Cerebrospinal fluid gamma-aminobutyric acid levels in migraine
3. Overview of diagnosis and treatment of migraine
4. Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma extravasation to substance P and trigeminal stimulation
5. In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat: Correlation to pharmacological activities
6. Valproate induced changes in GABA metabolism at the subcellular level
7. Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin
8. Sodium valproate in the prophylactic treatment of migraine: A double-blind study versus placebo
9. Migraine prophylaxis with divalproex
10. Sodium valproate has a prophylactic effect in migraine without aura: A triple-blind, placebocontrolled crossover study
11. Divalproex Sodium Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: A dosecontrolled study
12. A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura
13. Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better
14. Guidelines for controlled trials of drugs in migraine, 1st ed
15. On the combination of independent two sample tests of Wilcoxon